CD274 and neoplasm: APMK activation decreases the expression level of programmed cell death-ligand 1 (PD-L1, which acts as a brake to prevent T cells via binding to an immune checkpoint protein, PD-1, expressed on T cells), which induces cytotoxic T-cell-mediated tumor cell death [51, 55].